Bayram Cigerli Blog

Bigger İnfo Center and Archive

As the FDA evaluates ecstasy treatment for PTSD, questions mount about the evidence

Clinical trials of MDMA have been promising, but concerns have emerged about the quality of the research. A June hearing scheduled by the Food and Drug Administration is likely to address them.


http://dlvr.it/T6qSMl
Share

0 Comments:

Yorum Gönder